Applications & Trade , Sevelamer Hydrochloride, Sevelamer Carbonate, Colesevelam Hydrochloride
Primary Information Services

Home. Pharmaceutical Industry . Ordering Information . Contact.

Trade Technology Information - Contents on CD ROM

Information profile @ a Glance
  • Phosphate-binding therapy is considered integral to the
    management of hyperphosphatemia in hemodialysis patients.
  • Sevelamer Hydrochloride is a polymeric amine that binds phosphate and is meant for oral administration
  • Sevelamer Hydrochloride is a polycationpolymer and binds phosphorus in the gastrointestinal tract to facilitate phosphorus excretion in feces, thereby inhibiting phosphorus absorption from the gut, and thereby lowering the plasma phosphorus
  • Sevelamer reduced inpatient Medicare costs compared with calcium binders. However, when binder costs
    were added, overall PMPM costs favored calcium-treated over sevelamer-treated participants
  • There are at least indications that sevelamer may improve vascular and bone health and, perhaps, mortality
    in hemodialysis patients, whereas data on calcium-based binders are lacking
  • Lupin has entered in to settlement deal with Genzyme  for  Sevelamer that prevents a crucial blood disorder in patients with chronic renal failure. These products generated annual sales of USD700 million as per latest available data. As per settlement deal, Lupin would be able to launch these products before patent expiry in August 2013.

Basic Information

  • Chronic Kidney Disease: Current Status,Challenges and Management in India

  • Hyperphosphatemia

  • Hemodialysis - India

  • Kidney disease Statistics- USA

  • Economics of Sevelamer and Calcium-Based Phosphate Binders in Hemodialysis Patients

  • Experience with Phosphate Binders

  • The product Patent Regime - India

  • Patients Undergoing Hemodialysis

  • Treatment of hyperphosphatemia
    in Indian patients

  • Appraisal of sevelamer in the management of chronic renal failure

  • Peritoneal Dialysis - India

Technology & applications
  • Colesevelam Hydrochloride
  • Product Monograph: sevelamer hydrochloride
  • Consultant -Sevelamer: Comprehensive patent search
  • Consultant - Sevelamer: Key patent, SPC, and data exclusivity expiry
  • Product assessment : sevelamer carbonate
  • Research & Development
  • Research Article - colesevelam hcl
  • Process for the preparation of Sevelamer Hydrocholoride
  • Process for the preparation of Sevelamer Carbonate
  • Process for the preparation of Colesevelam Hydrochloride


Trade Scenario
  • Company & market share
  • Kidney Disease Statistics for the United States
  • Phosphate binders & Price factor
  • Use and costs of phosphate binders
  • The European marketing authorization
  • Sevelamer Carbonate-Market
    Research consultant
  • Listing for the treatment of hyperphosphataemia
  • Drug Price Listing
  • The shared care guideline
  • Sample Tender - India
  • Sample tender  - India

Companies & Products

  • Company - India

  • Company - India

  • Sevelamer  - msds

  • Colesevelam - msds

Companies & Performances

  • Performance of Companies in Health Care - India
  • Special Packaging Requirements
  • Company Annual Report -Switzerland
  • Indian Company - annual report
  • Company Presentation - Business Outlook
  • Company - Red Herring Prospectus
  • Company performance
  • Company - annual report
  • Company performance
  • Company performance
  • Company - distributor
  • Company in Litigation
  • Company growth

Order the CD ROM  Today


Primary Information Services
 21 Murugappan St, SwamyNagar Ext2, 
Ullagaram, Chennai - 600091, India.
Phone: 91 044 22421080   FAX : 91 44 22423753
Email :
Mobile numbers: 9940043898, 9444008898